Shares of drug firm Wockhardt settled in a positive territory today after the UK health regulator confirmed that its manufacturing facility at Chikalthana in Maharashtra complies with good manufacturing practices (GMP).
On BSE, the scrip settled 0.23 per cent up at Rs 683.50. It had opened at Rs 699 and jumped 3.24 per cent to an early high of Rs 704.
Following an uptick in the counter, the market capitalisation of the company rose by Rs 17.69 crore to Rs 7555.96 crore.
On NSE, the stock ended the day at Rs 685.40, up 0.39 per cent. It had opened at Rs 698.90 and rose 3.07 per cent to an early high of Rs 703.75.
On volume front, over 14 lakh shares of the company were traded on the exchanges.
In a BSE filing yesterday, Wockhardt said, "UK MHRA (UK Medicines and Healthcare products Regulatory Agency) has since confirmed that general compliance with the principles and guidelines of good manufacturing practice of the company's manufacturing unit at L-1, Chikalthana, Aurangabad.
Disclaimer: No Business Standard Journalist was involved in creation of this content
